Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy

被引:1
|
作者
Ye, Shuai [1 ]
Han, Yu [2 ]
Pan, Ximin [1 ]
Niu, Kexin [1 ]
Liao, Yuting [3 ]
Meng, Xiaochun [1 ]
机构
[1] Sun Yat sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China
[3] GE Healthcare Pharmaceut Diagnost, Guangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
radiomics; computed tomography; progression-free survival; colorectal liver metastases; chemotherapy;
D O I
10.3389/fonc.2023.1283480
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I-III Renal Cell Carcinoma
    Zhang, Haijie
    Yin, Fu
    Chen, Menglin
    Yang, Liyang
    Qi, Anqi
    Cui, Weiwei
    Yang, Shanshan
    Wen, Ge
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [22] CT-based AI radiomics model for predicting complete response and progression free survival of chemoradiotherapy in ESCC
    Kasai, Akinari
    Miyoshi, Jinsei
    Haga, Akihiro
    Kawanaka, Takashi
    Okamoto, Koichi
    Muguruma, Naoki
    Sato, Yasushi
    Takayama, Tetsuji
    CANCER SCIENCE, 2022, 113 : 1039 - 1039
  • [23] CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer
    Kai-Yu Sun
    Hang-Tong Hu
    Shu-Ling Chen
    Jin-Ning Ye
    Guang-Hua Li
    Li-Da Chen
    Jian-Jun Peng
    Shi-Ting Feng
    Yu-Jie Yuan
    Xun Hou
    Hui Wu
    Xin Li
    Ting-Fan Wu
    Wei Wang
    Jian-Bo Xu
    BMC Cancer, 20
  • [24] CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer
    Sun, Kai-Yu
    Hu, Hang-Tong
    Chen, Shu-Ling
    Ye, Jin-Ning
    Li, Guang-Hua
    Chen, Li-Da
    Peng, Jian-Jun
    Feng, Shi-Ting
    Hou, Xun
    Wu, Hui
    Li, Xin
    Wu, Ting-Fan
    Wang, Wei
    Xu, Jian-Bo
    BMC CANCER, 2020, 20 (01)
  • [25] Ultrasound-based radiomics score: a potential biomarker for the prediction of progression-free survival in ovarian epithelial cancer
    Fei Yao
    Jie Ding
    Zhangyong Hu
    Mengting Cai
    Jinjin Liu
    Xiaowan Huang
    Ruru Zheng
    Feng Lin
    Li Lan
    Abdominal Radiology, 2021, 46 : 4936 - 4945
  • [26] Ultrasound-based radiomics score: a potential biomarker for the prediction of progression-free survival in ovarian epithelial cancer
    Yao, Fei
    Ding, Jie
    Hu, Zhangyong
    Cai, Mengting
    Liu, Jinjin
    Huang, Xiaowan
    Zheng, Ruru
    Lin, Feng
    Lan, Li
    ABDOMINAL RADIOLOGY, 2021, 46 (10) : 4936 - 4945
  • [27] CT-Based Radiomic Biomarkers for Predicting Progression-Free Survival in Head and Neck Squamous Cell Carcinoma
    Ling, X.
    Bazyar, S.
    Ferris, M.
    Molitoris, J. K.
    Allor, E.
    Thomas, H.
    Arons, D.
    Schumaker, L.
    Krc, R. F.
    Mendes, W.
    Tran, P. T.
    Mehra, R.
    Gaykalova, D.
    Ren, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E766 - E766
  • [28] Oxaliplatin improves progression-free survival in patients with colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (01): : 83 - 83
  • [29] An MRI-based radiomics nomogram to predict progression-free survival in patients with endometrial cancer
    Liu, Ling
    Ji, Xiaodong
    Liang, Caihong
    Zhu, Jinxia
    Huang, Lixiang
    Zhao, Yujiao
    Xu, Xiangfeng
    Song, Zhiyi
    Shen, Wen
    FUTURE ONCOLOGY, 2024,
  • [30] The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer
    Muehlberg, Alexander
    Holch, Julian W.
    Heinemann, Volker
    Huber, Thomas
    Moltz, Jan
    Maurus, Stefan
    Jaeger, Nils
    Liu, Lian
    Froelich, Matthias F.
    Katzmann, Alexander
    Gresser, Eva
    Taubmann, Oliver
    Suehling, Michael
    Noerenberg, Dominik
    EUROPEAN RADIOLOGY, 2021, 31 (02) : 834 - 846